Position in ZTS
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$437,583,511
-$51,115,459 QoQ
Shares Held
3,701,747
-4.7% QoQ
Ownership
0.883%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 98.86364465210616.ToString("F0")%
None 1.136355347893846.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JANUS HENDERSON GROUP PLC holds $1,320,238,974 across 27 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (33.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
3,701,747 | $437,583,511 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
4,774,841 | $362,171,687 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,816,657 | $145,077,707 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
8,908,506 | $84,808,976 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
4,986,073 | $69,306,414 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
466,977 | $61,519,549 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,825,651 | $60,374,277 | |
| 8 | BIOA |
BioAge Labs, Inc.
|
2,094,270 | $36,628,782 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $437,583,511 | 3,701,747 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $488,698,970 | 3,884,112 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $335,180,636 | 2,290,737 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $333,786,958 | 2,140,346 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $325,723,142 | 1,978,276 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $261,748,346 | 1,606,508 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $346,029,701 | 1,771,060 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $310,976,807 | 1,793,821 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $350,057,415 | 2,068,775 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $514,852,078 | 2,608,563 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $542,768,884 | 3,119,720 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $546,719,735 | 3,174,727 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $331,230,411 | 1,990,089 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $261,934,821 | 1,787,341 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $274,408,716 | 1,850,487 | Shares | Defined | 2023-01-13 | |
| 2022-06-30 | $257,815,401 | 1,499,886 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $243,074,403 | 1,288,904 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $267,725,801 | 1,097,102 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $153,204,804 | 789,146 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $167,524,222 | 898,928 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $129,340,686 | 821,315 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $106,199,529 | 641,689 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $445,814,864 | 2,695,863 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $373,444,963 | 2,725,080 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $339,601,438 | 2,885,559 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||